The concentrations of antibodies to Epstein-Barr virus decrease during ocrelizumab treatment

Authors:

Abstract
No abstract available
Funding Information
  • Center for Clinical and Translational Sciences, University of Texas Health Science Center at Houston
  • Genentech (ML41627)
  • Health Science Center, University of North Texas
  • National Center for Advancing Translational Sciences
  • Center for Clinical and Translational Science, University of Illinois at Chicago (UL1TR003167)

This publication has 14 references indexed in Scilit: